Back
BridgeBio Pharma, Inc. Stock Price Chart
This Tech Company Grew 32,481%...
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
48
BBIO
BridgeBio Pharma, Inc.
Last Price:
$76.33
Seasonality Move:
-13.18%
7 Day Trial
ALL ACCESS PASS
$
7
-
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and BBIO is experiencing slight buying pressure.
BridgeBio Pharma, Inc. Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 74.57 | Buy |
| 20-day SMA: | 73.09 | Buy |
| 50-day SMA: | 65.78 | Buy |
| 200-day SMA: | 48.11 | Buy |
| 8-day EMA: | 74.58 | Buy |
| 20-day EMA: | 72.46 | Buy |
| 50-day EMA: | 66.82 | Buy |
| 200-day EMA: | 51.52 | Buy |
BridgeBio Pharma, Inc. Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 2.71 | Buy |
| Relative Strength Index (14 RSI): | 66.51 | Buy |
| Chaikin Money Flow: | 1873994 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (68.21 - 75.05) | Buy |
| Bollinger Bands (100): | (49.15 - 67.47) | Buy |
BridgeBio Pharma, Inc. Technical Analysis
| Dec 8 | Dec 9 | Dec 10 | Dec 11 | Dec 12 | Dec 15 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 08 | 09 | 10 | 11 | 12 | 15 | 16 | 17 | 18 | 19 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for BridgeBio Pharma, Inc. Stock
Is BridgeBio Pharma, Inc. Stock a Buy?
-
BridgeBio Pharma, Inc. share price is 76.30 while BBIO 8-day simple moving average is 74.57, which is a Buy signal.
-
The stock price of BBIO is 76.30 while BridgeBio Pharma, Inc. 20-day SMA is 73.09, which makes it a Buy.
-
BridgeBio Pharma, Inc. 50-day simple moving average is 65.78 while BBIO share price is 76.30, making it a Buy technically.
-
BBIO stock price is 76.30 and BridgeBio Pharma, Inc. 200-day simple moving average is 48.11, creating a Buy signal.
BBIO Technical Analysis vs Fundamental Analysis
Sell
48
BridgeBio Pharma, Inc. (BBIO)
is a Sell
Is BridgeBio Pharma, Inc. a Buy or a Sell?
-
BridgeBio Pharma, Inc. stock is rated a SellThe current BridgeBio Pharma, Inc. [BBIO] share price is $76.30. The Score for BBIO is 48, which is 4% below its historic median score of 50, and infers higher risk than normal.
BridgeBio Pharma, Inc. Stock Info
Market Cap:
14.7B
Price in USD:
76.30
Share Volume:
4.7M
BridgeBio Pharma, Inc. 52-Week Range
52-Week High:
77.20
52-Week Low:
26.02
Sell
48
BridgeBio Pharma, Inc. (BBIO)
is a Sell
BridgeBio Pharma, Inc. Share Price Forecast
-
What is the BridgeBio Pharma, Inc. stock price today?The BridgeBio Pharma, Inc. stock price is 76.30 USD today.
-
Will BBIO stock go up or go down?BridgeBio Pharma, Inc.> share price is forecast to RISE/FALL based on technical indicators
-
Is BridgeBio Pharma, Inc. overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, BridgeBio Pharma, Inc. is overvalued.
Is BridgeBio Pharma, Inc. Stock a Buy?
-
BridgeBio Pharma, Inc. share price is 76.30 while BBIO 8-day exponential moving average is 74.58, which is a Buy signal.
-
The stock price of BBIO is 76.30 while BridgeBio Pharma, Inc. 20-day EMA is 72.46, which makes it a Buy.
-
BridgeBio Pharma, Inc. 50-day exponential moving average is 66.82 while BBIO share price is 76.30, making it a Buy technically.
-
BBIO stock price is 76.30 and BridgeBio Pharma, Inc. 200-day simple moving average is 51.52, creating a Buy signal.
Fundamental Analysis of BridgeBio Pharma, Inc.
Is BridgeBio Pharma, Inc. a good investment?
-
Analysts estimate an earnings decrease this quarter of $0.33 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.80 per share, and an increase next year of $1.42 per share.
Technical Analysis of BridgeBio Pharma, Inc.
Should I short BridgeBio Pharma, Inc. stock?
-
BBIO Moving Average Covergence Divergence (MACD) indicator is 2.71, suggesting BridgeBio Pharma, Inc. is a Buy
-
BridgeBio Pharma, Inc. Relative Strength Index (RSI) is 66.51, which suggest BridgeBio Pharma, Inc. is overbought
-
The Bollinger Bands (25) for BridgeBio Pharma, Inc. is (68.21 - 75.05), which suggest BridgeBio Pharma, Inc. is a Buy
-
The Bollinger Bands (100) for BridgeBio Pharma, Inc. is (49.15 - 67.47), which suggest BridgeBio Pharma, Inc. is a Buy
* BridgeBio Pharma, Inc. stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.